CDK5 and Alzheimer disease: It has been shown that activation of IL-1β signaling triggers the activation of kinases CDK5, GSK3β, and p38 mitogen-activated protein kinase (p38-MAPK), resulting in tau hyperphosphorylation and cognitive impairment in the 3xTg-AD mouse model [130].